Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Blood volume regulation is a physiologic process responsible for maintaining the adequate circulating blood volume needed to ensure tissue perfusion and homeostasis. It is mediated by the integrated actions of the renal system (regulating sodium and water reabsorption), cardiovascular system (regulating vascular tone and cardiac output), autonomic nervous system, and hormones such as the renin-angiotensin-aldosterone system (RAAS) and vasopressin (ADH)[1][3][7][9]. Drugs, notably diuretics, ACE inhibitors, angiotensin receptor blockers, aldosterone antagonists, and vasopressin antagonists, act on components of this process, but "blood volume regulation" per se is not a single molecular drug target[7]. Blood volume regulation is a physiologic or functional process, not a molecular target; it encompasses numerous molecular targets that coordinate to maintain blood volume and pressure homeostasis[1][3][7][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Blood volume regulation.